🇺🇸 Inavtivated Quadrivalent Influenza Virus Split Vaccine in United States

Inavtivated Quadrivalent Influenza Virus Split Vaccine (Inavtivated Quadrivalent Influenza Virus Split Vaccine) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Inavtivated Quadrivalent Influenza Virus Split Vaccine in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Inavtivated Quadrivalent Influenza Virus Split Vaccine approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Inavtivated Quadrivalent Influenza Virus Split Vaccine in United States?

Wuhan Institute of Biological Products Co., Ltd is the originator. The local marketing authorisation holder may differ — check the official source linked above.